Please Wait
Applying Filters...
menu
    • menu
    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Abatacept

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kashiv Phase 1 Success For Abatacept Biosimilar Candidate KSHB002
    Kashiv Phase 1 Success For Abatacept Biosimilar Candidate KSHB002

    28 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250128004632/en

    BUSINESSWIRE
    28 Jan 2025
    Share Share
    Bristol Myers Squibb's Biologic Orencia (abatacept) Receives Approval in the U.S.
    Bristol Myers Squibb's Biologic Orencia (abatacept) Receives Approval in the U.S.

    30 Oct 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125118

    FDA
    30 Oct 2023
    Share Share
    Coya announces an Agreement with Dr. Reddy’s to License biosimilar Abatacept
    Coya announces an Agreement with Dr. Reddy’s to License biosimilar Abatacept

    21 Mar 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230317005028/en

    BUSINESSWIRE
    21 Mar 2023
    Share Share
    NIH-led Covid-19 trial shows immune modulator drugs boost survival
    NIH-led Covid-19 trial shows immune modulator drugs boost survival

    18 Jul 2022

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/nih-covid-trial-survival/

    CLINICALTRIALSARENA
    18 Jul 2022
    Share Share
    Immune modulator drugs improves survival for people hospitalised with COVID-19
    Immune modulator drugs improves survival for people hospitalised with COVID-19

    03 Jun 2022

    // EXPRESS PHARMA

    https://www.expresspharma.in/immune-modulator-drugs-improves-survival-for-people-hospitalised-with-covid-19/

    EXPRESS PHARMA
    03 Jun 2022
    Share Share
    BMS’ Orencia boosts survival in Phase III Covid-19 trial
    BMS’ Orencia boosts survival in Phase III Covid-19 trial

    03 Jun 2022

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/bms-orencia-covid-trial/

    CLINICALTRIALSARENA
    03 Jun 2022
    Share Share